UB Paderborn / Katalog / Suche / in CDI

In vitro evaluation of the internalization and toxicological profile of silica nanoparticles and submicroparticles for the design of dermal drug delivery strategies

Journal of applied toxicology, 2017-12, Vol.37 (12), p.1396-1407

2017

Link zum Volltext

Verfügbarkeit prüfen

Prostaglandin EP2 receptor signaling protects human trabecular meshwork cells from apoptosis induced by ER stress through down-regulation of p53

Biochimica et biophysica acta, 2016-09, Vol.1863 (9), p.2322-2332

2016

Link zum Volltext

Verfügbarkeit prüfen

The mGluR2 positive allosteric modulator, SAR218645, improves memory and attention deficits in translational models of cognitive symptoms associated with schizophrenia

Scientific reports, 2016-10, Vol.6 (1), p.35320-35320, Article 35320

2016

Link zum Volltext

Verfügbarkeit prüfen

Activation of Prostaglandin FP and EP2 Receptors Differently Modulates Myofibroblast Transition in a Model of Adult Primary Human Trabecular Meshwork Cells

Investigative ophthalmology & visual science, 2016-04, Vol.57 (4), p.1816-1825

2016

Link zum Volltext

Verfügbarkeit prüfen

Development of a novel NURR1/NOT agonist from hit to lead and candidate for the potential treatment of Parkinson's disease

Bioorganic & medicinal chemistry letters, 2019-04, Vol.29 (7), p.929-932

2019

Link zum Volltext

Verfügbarkeit prüfen

A 3D Human Liver Model of Nonalcoholic Steatohepatitis

Journal of clinical and translational hepatology, 2020-12, Vol.8 (4), p.359-370

2020

Link zum Volltext

Verfügbarkeit prüfen

Characterization of SSR103800, a selective inhibitor of the glycine transporter-1 in models predictive of therapeutic activity in schizophrenia

Pharmacology, biochemistry and behavior, 2008-11, Vol.91 (1), p.47-58

2008

Link zum Volltext

Verfügbarkeit prüfen

Data on synthesis, ADME and pharmacological properties and early safety pharmacology evaluation of a series of novel NURR1/NOT agonist potentially useful for the treatment of Parkinson's disease

Data in brief, 2019-12, Vol.27, p.104057-104057, Article 104057

2019

Link zum Volltext

Verfügbarkeit prüfen

Dual effects of thrombin and a 14-amino acid peptide agonist of the thrombin receptor on septal cholinergic neurons

Brain research, 1996-02, Vol.708 (1), p.159-166

1996

Link zum Volltext

Verfügbarkeit prüfen

Fractalkine modulates TNF-α secretion and neurotoxicity induced by microglial activation

Glia, 2000-02, Vol.29 (4), p.305-315

2000

Link zum Volltext

Verfügbarkeit prüfen

Modulation of the gamma-aminobutyric acid type A receptor by the antiepileptic drugs carbamazepine and phenytoin

Molecular pharmacology, 1995-06, Vol.47 (6), p.1189-1196

1995

Link zum Volltext

Verfügbarkeit prüfen

Scopolamine induces up-regulation of nicotinic receptors in intact brain but not in nucleus basalis lesioned rats

Neuroscience letters, 1988-06, Vol.88 (3), p.319-324

1988

Link zum Volltext

Verfügbarkeit prüfen

Regulation by Interleukin‐1 of Nerve Growth Factor Secretion and Nerve Growth Factor mRNA Expression in Rat Primary Astroglial Cultures

Journal of neurochemistry, 1991-02, Vol.56 (2), p.636-643

1991

Link zum Volltext

Verfügbarkeit prüfen

Transduction Mechanisms Involved in Thrombin Receptor‐Induced Nerve Growth Factor Secretion and Cell Division in Primary Cultures of Astrocytes

Journal of neurochemistry, 1996-06, Vol.66 (6), p.2320-2328

1996

Link zum Volltext

Verfügbarkeit prüfen

Pharmacological characterization of protease-activated receptor (PAR-1) in rat astrocytes

European journal of pharmacology, 1997-03, Vol.323 (1), p.111-117

1997

Link zum Volltext

Verfügbarkeit prüfen

Mechanism of nerve growth factor mRNA regulation by interleukin-1 and basic fibroblast growth factor in primary cultures of rat astrocytes

Molecular pharmacology, 1991-08, Vol.40 (2), p.186-192

1991

Link zum Volltext

Verfügbarkeit prüfen

SSR240600 [(R)-2-(1-[2-[4-[2-[3,5-bis(trifluoromethyl)phenyl]acetyl]-2-(3,4-dichlorophenyl)-2-morpholinyl]ethyl]- 4-piperidinyl)-2-methylpropanamide], a centrally active nonpeptide antagonist of the tachykinin neurokinin-1 receptor: I. biochemical and pharmacological characterization

The Journal of pharmacology and experimental therapeutics, 2002-12, Vol.303 (3), p.1171

2002

Link zum Volltext

Verfügbarkeit prüfen

Cortical neurons inhibit basal and interleukin-1-stimulated astroglial cell secretion of nerve growth factor

Brain research, 1992-09, Vol.591 (2), p.345-350

1992

Link zum Volltext

Verfügbarkeit prüfen

Neuroprotective efficacy of [formula omitted] after focal cerebral ischemia in the mouse and inhibition of cortical nitric oxide synthase

European journal of pharmacology, 1994-05, Vol.256 (3), p.241-249

1994

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

In vitro evaluation of the internalization and toxicological profile of silica nanoparticles and submicroparticles for the design of dermal drug delivery strategies

Prostaglandin EP2 receptor signaling protects human trabecular meshwork cells from apoptosis induced by ER stress through down-regulation of p53

The mGluR2 positive allosteric modulator, SAR218645, improves memory and attention deficits in translational models of cognitive symptoms associated with schizophrenia

Activation of Prostaglandin FP and EP2 Receptors Differently Modulates Myofibroblast Transition in a Model of Adult Primary Human Trabecular Meshwork Cells

Development of a novel NURR1/NOT agonist from hit to lead and candidate for the potential treatment of Parkinson's disease

A 3D Human Liver Model of Nonalcoholic Steatohepatitis

Characterization of SSR103800, a selective inhibitor of the glycine transporter-1 in models predictive of therapeutic activity in schizophrenia

Data on synthesis, ADME and pharmacological properties and early safety pharmacology evaluation of a series of novel NURR1/NOT agonist potentially useful for the treatment of Parkinson's disease

Neurochemical, Electrophysiological and Pharmacological Profiles of the Selective Inhibitor of the Glycine Transporter-1 SSR504734, a Potential New Type of Antipsychotic

SSR180711, a Novel Selective α7 Nicotinic Receptor Partial Agonist: (1) Binding and Functional Profile

SSR180711, a novel selective alpha 7 nicotinic receptor partial agonist: (I) binding and functional profile

Dual effects of thrombin and a 14-amino acid peptide agonist of the thrombin receptor on septal cholinergic neurons

Fractalkine modulates TNF-α secretion and neurotoxicity induced by microglial activation

Modulation of the gamma-aminobutyric acid type A receptor by the antiepileptic drugs carbamazepine and phenytoin

SSRI80711, a novel selective α7 nicotinic receptor partial agonist: (I) binding and functional profile

Scopolamine induces up-regulation of nicotinic receptors in intact brain but not in nucleus basalis lesioned rats

Regulation by Interleukin‐1 of Nerve Growth Factor Secretion and Nerve Growth Factor mRNA Expression in Rat Primary Astroglial Cultures

Transduction Mechanisms Involved in Thrombin Receptor‐Induced Nerve Growth Factor Secretion and Cell Division in Primary Cultures of Astrocytes

Pharmacological characterization of protease-activated receptor (PAR-1) in rat astrocytes

Mechanism of nerve growth factor mRNA regulation by interleukin-1 and basic fibroblast growth factor in primary cultures of rat astrocytes

SSR180711, a novel selective alpha7 nicotinic receptor partial agonist: (1) binding and functional profile

SSR240600 [(R)-2-(1-[2-[4-[2-[3,5-bis(trifluoromethyl)phenyl]acetyl]-2-(3,4-dichlorophenyl)-2-morpholinyl]ethyl]- 4-piperidinyl)-2-methylpropanamide], a centrally active nonpeptide antagonist of the tachykinin neurokinin-1 receptor: I. biochemical and pharmacological characterization

Cortical neurons inhibit basal and interleukin-1-stimulated astroglial cell secretion of nerve growth factor

Neuroprotective efficacy of [formula omitted] after focal cerebral ischemia in the mouse and inhibition of cortical nitric oxide synthase

Suchergebnisse filtern